Ignite Creation Date:
2024-05-06 @ 3:52 PM
Last Modification Date:
2024-10-26 @ 1:58 PM
Study NCT ID:
NCT04782193
Status:
RECRUITING
Last Update Posted:
2023-04-18
First Post:
2021-02-26
Brief Title:
a Clinical Research of CD19 and CD22 Targeted Prime CAR-T Cell in RelapsedRefractory B Cell Lymphoma
Sponsor:
Chongqing Precision Biotech Co Ltd
Organization:
Chongqing Precision Biotech Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-05-23
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-07-01
Completion Date Type:
ESTIMATED
First Submit Date:
2021-02-26
First Submit QC Date:
March 2 2021
Study First Post Date:
2021-03-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-16
Last Update Post Date:
2023-04-18
Last Update Post Date Type:
ACTUAL